Your browser doesn't support javascript.
loading
Two new compounds from biotransformation of glycyrrhetinic acid.
Xie, Zehao; Gu, Xinxin; Dekebo, Aman; Wei, Shaozhong; Hu, Xuebo.
Afiliação
  • Xie Z; Institute for Medicinal Plants, College of Plant Science and Technology, Huazhong Agricultural University, Wuhan, China, Innovation Academy of International Traditional Chinese Medicinal Materials, Huazhong Agricultural University, Wuhan, China, National-Regional Joint Engineering Research Center in
  • Gu X; Institute for Medicinal Plants, College of Plant Science and Technology, Huazhong Agricultural University, Wuhan, China, Innovation Academy of International Traditional Chinese Medicinal Materials, Huazhong Agricultural University, Wuhan, China, National-Regional Joint Engineering Research Center in
  • Dekebo A; Applied Chemistry Department, School of Applied Natural Sciences, Adama Science and Technology University, Adama, Ethiopia, Institute of Pharmaceutical Sciences, Adama Science and Technology University, Adama, Ethiopia.
  • Wei S; Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Colorectal cancer clinical research center of Hubei Province, Colorectal Cancer Clinical Research Center of Wuhan, China.
  • Hu X; Institute for Medicinal Plants, College of Plant Science and Technology, Huazhong Agricultural University, Wuhan, China, Innovation Academy of International Traditional Chinese Medicinal Materials, Huazhong Agricultural University, Wuhan, China, National-Regional Joint Engineering Research Center in
Nat Prod Res ; : 1-5, 2024 Feb 01.
Article em En | MEDLINE | ID: mdl-38303502
ABSTRACT
Glycyrrhetinic acid may undergo biotransformation to obtain derivatives with stronger pharmacological activity and fewer side effects. This study used 19 fungi to biotransform glycyrrhetinic acid and yielded two compounds namely bicyclo(14.15.27)glycyrrhetinic acid (1) and 2-ene-glycyrrhetinic acid (2) from the glycyrrhetinic acid metabolites of two fungi, Botrytis cinerea B05.10 ATCC 11542 and Aspergillus ochraceopetaliformis ATCC 12066. Compound 1 inhibited HMEC-1 cell proliferation in a concentration-dependent manner (IC50=239.1 µ M), but showed no significant cytotoxicity to A549 cells.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Nat Prod Res Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Nat Prod Res Ano de publicação: 2024 Tipo de documento: Article